Altos Labs Stock

altoslabs.comHealthcareFounded: 2021Funding to Date: $336.39MM

Altos Labs manufactures beauty products using biological reprogramming to reverse the aging process and offer anti-aging treatments.

Register for Details

For more details on financing and valuation for Altos Labs, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Altos Labs.

Register Today

Altos Labs investors also invested in these private companies

Jeff Bezos
Yuri Milner

Team

Management Team

Yuri Milner
Founder
Rick Klausner
Founder & Chief Scientist
Hal Barron
Incoming Chief Executive Officer
Hans Bishop
Founder & President
Ann Lee-Karlon
Chief Operating Officer
Laurie Hill
General Counsel

Board Members

Frances Arnold
California Institute of Technology
David Baltimore
Emeritus & Caltech
Jennifer Doudna
University of California
Maria Leptin
EMBL
Robert Nelsen
ARCH Venture Partners
Rajiv Shah
Rockefeller Foundation
Karl Johansson

Other companies like Altos Labs in the Healthcare sector

Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$67.5MM
Sector
Last Round Est. Valuation
$1.19B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$4.65B

News

Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep biology of cellular rejuvenation programming. Altos' mission is to restore cell health and resilience to reverse disease, injury, and the disabilities that can occur throughout life. The company launches with a community of leading scientists, clinicians, and leaders from both academia and industry working together towards this common mission.